IE
ATRC icon

Israel Englander’s AtriCure ATRC Stock Holding History

Israel Englander’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$304K – 5864
2024
Q1 		$304K Buy
+10,000
New +$335K ﹤0.01% 5133
2023
Q1 		– Sell
-10,000
Closed -$444K – 6349
2022
Q4 		$444K Buy
+10,000
New +$418K ﹤0.01% 4828
2021
Q4 		– Sell
-10,000
Closed -$696K – 6760
2021
Q3 		$696K Buy
+10,000
New +$770K ﹤0.01% 5025

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Israel Englander's ATRC Position: Q2 2026 in Review

Israel Englander sold out of AtriCure (ATRC) in Q2 2026, closing a stake of 179,886 shares — an estimated $5.13M sold.

Israel Englander first reported a position in ATRC in Q3 2013 and held it in 48 quarters. The position peaked at $68.8M in Q4 2021. 250 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Israel Englander reported no remaining AtriCure position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 179,886 AtriCure shares in Q2 2026, an estimated $5.13M.
  • Israel Englander first reported a position in AtriCure in Q3 2013 and held it in 48 quarters.
  • Israel Englander's AtriCure position peaked at $68.8M in Q4 2021.
  • 250 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.